Drugs / ARO-INHBE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06700538 | Dec 2024 → Sep 2027 expected | obesity disorder | Arrowhead Pharmaceuticals | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARO-INHBE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06700538 ↗ |
| Route | Subcutaneous | “Subcutaneous (SC) injection” NCT06700538 ↗ |